Biocon Shares Shot Up 3% on Securing Remaining Approvals from USFDA 

March 5, 2025March 5, 2025

Shares of pharmaceutical main Biocon Ltd had been buying and selling within the inexperienced and three% greater on 5 March after the corporate that its wholly-owned subsidiary secured remaining approval for Lenalidomide capsules and Dasatinib tablets from USFDA. 

In its regulatory submitting, the corporate mentioned, “That is to tell you that Biocon Pharma Restricted, an entirely owned subsidiary of the Firm, has acquired remaining approvals for its ANDAs from the US Meals and Drug Administration (USFDA).”

Lenalidomide Capsules can be found in doses of two.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg. This remedy is used to deal with a number of myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anaemia linked to myelodysplastic syndromes (MDS) in adults.

In the meantime, Dasatinib Tablets are available in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. It’s prescribed for Philadelphia chromosome-positive persistent myeloid leukaemia (Ph+ CML) in adults and youngsters aged one yr and older. Moreover, it’s used to deal with Ph+ CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) in adults when earlier remedies, resembling imatinib, are ineffective. In youngsters aged one yr and older, Dasatinib will also be used alongside chemotherapy for newly identified Ph+ ALL.

Biocon Pharma has additionally acquired tentative approval for its Abbreviated New Drug Utility (ANDA) for Rivaroxaban Tablets USP, out there in strengths of two.5 mg, 10 mg, 15 mg, and 20 mg, in line with the corporate’s assertion.

Rivaroxaban is indicated for treating deep vein thrombosis and pulmonary embolism, in addition to lowering the chance of stroke and systemic embolism in sufferers with nonvalvular atrial fibrillation, amongst different situations.

These approvals additional strengthen Biocon’s portfolio of complicated, vertically built-in drug merchandise, the corporate added.

At 3:21 pm, the shares of Biocon had been buying and selling 3.19% greater at Rs 324.85 on NSE.

Navigate Biocon Ltd Like a Professional. Ask the Analyst.

Bored with lacking sizzling shares? Unicorn Alerts supplies highly effective instruments like inventory scans and extra assist you make knowledgeable buying and selling choices. Obtain now and take management of your portfolio!